Suvretta Capital Management, LLC 89bio, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.39 Billion
- Q2 2024
A detailed history of Suvretta Capital Management, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 8,031,845 shares of ETNB stock, worth $65.7 Million. This represents 2.69% of its overall portfolio holdings.
Number of Shares
8,031,845
Previous 6,298,004
27.53%
Holding current value
$65.7 Million
Previous $73.3 Million
12.24%
% of portfolio
2.69%
Previous 3.14%
Shares
6 transactions
Others Institutions Holding ETNB
# of Institutions
157Shares Held
107MCall Options Held
65KPut Options Held
1.2M-
Ra Capital Management, L.P. Boston, MA14.2MShares$116 Million1.71% of portfolio
-
Janus Henderson Group PLC London, X013.3MShares$109 Million0.06% of portfolio
-
Bvf Inc San Francisco, CA7.57MShares$61.9 Million1.85% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$60.4 Million0.99% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$57.4 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $380M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...